Please wait while the formulary information is being retrieved.
KALBITOR (ECALLANTIDE)
- Hereditary angioedema
10 mg/mL (1 mL) subcutaneous solution
- Inject 3 milliliters (30 mg) as 3 divided injections of 1 ml (10 mg) by subcutaneous route once; may repeat 30 mg dose once within 24 hours
Hereditary angioedema
- Inject 3 milliliters (30 mg) as 3 equally divided injections of 1 ml (10 mg) each by subcutaneous route once; may repeat 30 mg dose once within a 24 hour period
- Inject 3 milliliters (30 mg) as 3 divided injections of 1 ml (10 mg) by subcutaneous route once; may repeat 30 mg dose once within 24 hours
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- No disease contraindications
KALBITOR (ECALLANTIDE)
- Hereditary angioedema
- None
- Diarrhea
- Fatigue
- Headache disorder
- Injection site sequelae
- Nausea
- Pharyngitis
- Upper respiratory infection
- Vomiting
More Frequent
Severe
Less Severe
- Anaphylaxis
- Hypersensitivity drug reaction
- Urticaria
- Fever
- Pruritus of skin
- Skin rash
- Upper abdominal pain
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Ecallantide
No unanticipated safety issues identified in limited pediatric studies.
- 1 Day – 16 Years
- No unanticipated safety issues identified in limited pediatric studies.
Ecallantide
- Severity Level:
C
- Additional Notes: Insufficient human data
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Ecallantide
Insufficient human data
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- Ecallantide may rarely cause serious (rarely fatal) allergic reactions. Patients who experience a severe allergic reaction with this drug must never use it again. Because the symptoms can be the same for an allergic reaction and the condition which this medication treats, you will be monitored closely by your healthcare providers as you receive this medication in a clinic or hospital. Immediate medical attention should be provided if you develop any signs of an allergic reaction such as rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing, or chest pain.
| Hereditary angioedema | |
| D84.1 | Defects in the complement system |
| 0-9 | A-Z |
|---|---|
| D84.1 | Defects in the complement system |
Formulary Reference Tool